Preferred Label : Nephrotic syndrome, type 3;
Symbol : NPHS3;
CISMeF acronym : NPHS3;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Nephrotic syndrome, early-onset, type 3;
Description : Nephrotic syndrome, a malfunction of the glomerular filter, is characterized clinically
by proteinuria, edema, and end-stage renal disease (ESRD). Renal histopathology may
show diffuse mesangial sclerosis (DMS) or focal segmental glomerulosclerosis (FSGS)
(Hinkes et al., 2006). Most patients with NPHS3 show diffuse mesangial sclerosis on
renal biopsy, which is a pathologic entity characterized by mesangial matrix expansion
with no mesangial hypercellularity, hypertrophy of the podocytes, vacuolized podocytes,
thickened basement membranes, and diminished patency of the capillary lumen (Gbadegesin
et al., 2008). For a general phenotypic description and a discussion of genetic heterogeneity
of nephrotic syndrome and FSGS, see NPHS1 (256300).;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the phospholipase C, epsilon-1 gene (PLCE1, 608414.0001);
Laboratory abnormalities : Proteinuria; Hypoalbuminemia;
Prefixed ID : #610725;
Origin ID : 610725;
UMLS CUI : C1853124;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)